References

Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths ‐ United States, 2013‐2019

10.15585/mmwr.mm7006a4 · 2021 · External reference

Management of Opioid Use Disorder in the USA: Present Status and Future Directions

10.1016/s0140-6736(18)33078-2 · 2019 · External reference

Comparison of Opioids Prescribed for Patients at Risk for Opioid Misuse Before and After Publication of the Centers for Disease Control and Prevention's Opioid Prescribing Guidelines

10.1001/jamanetworkopen.2020.27481 · 2020 · External reference

Recovery From Opioid Use Disorder (OUD) After Monthly Long‐Acting Buprenorphine Treatment: 12‐Month Longitudinal Outcomes From RECOVER, an Observational Study

10.1097/adm.0000000000000647 · 2020 · External reference

The Hidden Epidemic of Opioid Overdoses During the Coronavirus Disease 2019 Pandemic

10.1001/jamapsychiatry.2020.4148 · 2021 · External reference

Medication‐Assisted Treatment for Opioid‐Use Disorder

10.1016/j.mayocp.2019.03.029 · 2019 · External reference

Unresolved reference

External reference

Unresolved reference

2000 · External reference

Semaglutide and Opioid Overdose Risk in Patients With Type 2 Diabetes and Opioid Use Disorder

10.1001/jamanetworkopen.2024.35247 · 2024 · External reference

The Association Between Glucose‐Dependent Insulinotropic Polypeptide and/or Glucagon‐Like Peptide‐1 Receptor Agonist Prescriptions and Substance‐Related Outcomes in Patients With Opioid and Alcohol Use Disorders: A Real‐World Data Analysis

10.1111/add.16679 · 2025 · External reference

Activation of GLP‐1 Receptors Attenuates Oxycodone Taking and Seeking Without Compromising the Antinociceptive Effects of Oxycodone in Rats

10.1038/s41386-019-0531-4 · 2020 · External reference

Rescue of HSP70 in Spinal Neurons Alleviates Opioids‐Induced Hyperalgesia via the Suppression of Endoplasmic Reticulum Stress in Rodents

10.3389/fcell.2020.00269 · 2020 · External reference

TSPAN5 Influences Serotonin and Kynurenine: Pharmacogenomic Mechanisms Related to Alcohol Use Disorder and Acamprosate Treatment Response

2020 · External reference

Genetic Contributions to Alcohol Use Disorder Treatment Outcomes: A Genome‐Wide Pharmacogenomics Study

10.1038/s41386-021-01097-0 · 2021 · External reference

Single Cell Transcriptomics Reveals Distinct Transcriptional Responses to Oxycodone and Buprenorphine by iPSC‐Derived Brain Organoids From Patients With Opioid Use Disorder

2022 · External reference

Generation of Human Brain Region–Specific Organoids Using a Miniaturized Spinning Bioreactor

10.1038/nprot.2017.152 · 2018 · External reference

Genetic Variants Associated With Acamprosate Treatment Response in Alcohol Use Disorder Patients: A Multiple Omics Study

2022 · External reference

TSPAN5, an Alcohol Responsive Gene That Alters Serotonin Levels in Human Induced Pluripotent Stem Cells: Novel Molecular Links to Alcohol Use Disorder

2019 · External reference

Synaptic Dysregulation in a Human iPS Cell Model of Mental Disorders

10.1038/nature13716 · 2014 · External reference

Pharmacokinetics of Non‐Intravenous Formulations of Fentanyl

10.1007/s40262-012-0016-7 · 2013 · External reference

Liraglutide in Type 2 Diabetes Mellitus: Clinical Pharmacokinetics and Pharmacodynamics

10.1007/s40262-015-0343-6 · 2016 · External reference

Population Pharmacokinetics of Exenatide

10.1111/bcp.13135 · 2017 · External reference

Population Pharmacokinetics of the GIP/GLP Receptor Agonist Tirzepatide

2024 · External reference

Factors Influencing Topiramate Clearance in Adult Patients With Epilepsy: A Population Pharmacokinetic Analysis

10.1016/j.seizure.2016.02.002 · 2016 · External reference

Pharmacokinetics of Immediate Release, Extended Release, and Gastric Retentive Gabapentin Formulations in Healthy Adults

10.5414/cp203166 · 2018 · External reference

The Population Pharmacokinetics of D‐β‐Hydroxybutyrate Following Administration of (R)‐3‐Hydroxybutyl (R)‐3‐Hydroxybutyrate

10.1208/s12248-016-9879-0 · 2016 · External reference

STAR: Ultrafast Universal RNA‐Seq Aligner

2013 · External reference

Moderated Estimation of Fold Change and Dispersion for RNA‐Seq Data With DESeq2

10.1186/s13059-014-0550-8 · 2014 · External reference

Gene Set Enrichment Analysis: A Knowledge‐Based Approach for Interpreting Genome‐Wide Expression Profiles

10.1073/pnas.0506580102 · 2005 · External reference

PGC‐1α‐Responsive Genes Involved in Oxidative Phosphorylation Are Coordinately Downregulated in Human Diabetes

10.1038/ng1180 · 2003 · External reference

Systematic and Integrative Analysis of Large Gene Lists Using DAVID Bioinformatics Resources

10.1038/nprot.2008.211 · 2009 · External reference

DAVID: A Web Server for Functional Enrichment Analysis and Functional Annotation of Gene Lists (2021 Update)

10.1093/nar/gkac194 · 2022 · External reference

ChEA3: Transcription Factor Enrichment Analysis by Orthogonal Omics Integration

10.1093/nar/gkz446 · 2019 · External reference

TRIB3 Alters Endoplasmic Reticulum Stress‐Induced β‐Cell Apoptosis via the NF‐κB Pathway

10.1016/j.metabol.2014.03.003 · 2014 · External reference

Tribbles Homolog 3 Mediates the Development and Progression of Diabetic Retinopathy

10.2337/db20-1268 · 2021 · External reference

TRB3, a Novel ER Stress‐Inducible Gene, Is Induced via ATF4‐CHOP Pathway and Is Involved in Cell Death

10.1038/sj.emboj.7600596 · 2005 · External reference

Characterization of Human NIPK (TRB3, SKIP3) Gene Activation in Stressful Conditions

10.1016/j.bbrc.2005.02.149 · 2005 · External reference

STRING v10: Protein‐Protein Interaction Networks, Integrated Over the Tree of Life

10.1093/nar/gku1003 · 2015 · External reference

Semaglutide and Tirzepatide Reduce Alcohol Consumption in Individuals With Obesity

10.1038/s41598-023-48267-2 · 2023 · External reference

Importance of Gabapentin Dose in Treatment of Opioid Withdrawal

10.1097/jcp.0b013e31822bb378 · 2011 · External reference

The Effect of Topiramate in the Treatment of Opioid (Heroin) Withdrawal

10.1016/s0924-9338(09)70676-5 · 2009 · External reference

Ketogenic Diet: A Potential Adjunctive Treatment for Substance Use Disorders

10.3389/fnut.2023.1191903 · 2023 · External reference

Ketogenic Diet Enhances the Effects of Oxycodone in Mice

10.1038/s41598-023-33458-8 · 2023 · External reference

Ketogenic Diet Reduces Alcohol Withdrawal Symptoms in Humans and Alcohol Intake in Rodents

10.1126/sciadv.abf6780 · 2021 · External reference

A Review of Toxicological Profile of Fentanyl—A 2024 Update

10.3390/toxics12100690 · 2024 · External reference

CCAAT/Enhancer Binding Protein β in Relation to ER Stress, Inflammation, and Metabolic Disturbances

2015 · External reference

C/EBPβ: A Transcription Factor Associated With the Irreversible Progression of Alzheimer's Disease

10.1111/cns.14721 · 2024 · External reference

Liraglutide Counteracts Endoplasmic Reticulum Stress in Palmitate‐Treated Hypothalamic Neurons Without Restoring Mitochondrial Homeostasis

10.3390/ijms24010629 · 2023 · External reference

The Association Between Neuropsychiatric Effects of Substance Use and Occurrence of Endoplasmic Reticulum and Unfolded Protein Response: A Systematic Review

10.1016/j.toxlet.2023.12.008 · 2024 · External reference

Endoplasmic Reticulum Stress and Inflammation in the Central Nervous System

10.1186/s13024-017-0183-y · 2017 · External reference

Association of Semaglutide With Risk of Suicidal Ideation in a Real‐World Cohort

10.1038/s41591-023-02672-2 · 2024 · External reference

Use of GLP‐1 Receptor Agonists and Subsequent Risk of Alcohol‐Related Events. A Nationwide Register‐Based Cohort and Self‐Controlled Case Series Study

10.1111/bcpt.13776 · 2022 · External reference

Drug Addiction and Its Underlying Neurobiological Basis: Neuroimaging Evidence for the Involvement of the Frontal Cortex

10.1176/appi.ajp.159.10.1642 · 2002 · External reference

The Neurobiology of Drug Addiction: Cross‐Species Insights Into the Dysfunction and Recovery of the Prefrontal Cortex

10.1038/s41386-021-01153-9 · 2022 · External reference